-
Mashup Score: 30New mRNA Pancreatic Cancer Vaccine Trial Starts Next Phase After - 9 month(s) ago
Learn how MSK researchers are deploying mRNA vaccines against pancreatic cancer.
Source: www.mskcc.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1A Vaccine for Pancreatic Cancer Treatment? - 12 month(s) ago
I have to say, this new paper is good news on the oncology front. It’s from researchers at Sloan-Kettering and BioNTech (among others) and presents the results of a small trial treating patients with pancreatic cancer, specifically pancreatic ductal adenocarcinoma (PDAC). This is another crack at the “personalized cancer therapy” idea and simultaneously at the “cancer vaccine” idea, and it’s fair…
Source: www.science.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 3Vaccine boosts T cells that target pancreatic tumours - 12 month(s) ago
Clinical trial tests a personalized approach to treat pancreatic cancer.
Source: www.nature.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer - Nature - 12 month(s) ago
A phase I clinical trial of an adjuvant personalized mRNA neoantigen vaccine, autogene cevumeran, in patients with pancreatic ductal carcinoma demonstrates that the vaccine can induce T cell activity that may correlate with delayed recurrence of disease.
Source: NatureCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer - PubMed - 12 month(s) ago
Pancreatic ductal adenocarcinoma (PDAC) is lethal in 88% of patients1, yet harbours mutation-derived T cell neoantigens that are suitable for vaccines 2,3. Here in a phase I trial of adjuvant autogene cevumeran, an individualized neoantigen vaccine based on uridine mRNA-lipople …
Source: PubMedCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1Personalized mRNA Vaccine Immunogenic against PDAC - 12 month(s) ago
Neoantigen vaccine induces T cells that seem to delay tumor recurrence.
Categories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 2An mRNA vaccine that programs the body to fight pancreatic cancer shows early promise | CNN - 12 month(s) ago
Of the 16 patients who were able to complete all phases of the study, eight responded to the vaccine, which taught their immune systems how to recognize and fight off the cancer cells. None of those eight has seen their cancer return.
Source: CNNCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 2Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer - Nature - 12 month(s) ago
A phase I clinical trial of an adjuvant personalized mRNA neoantigen vaccine, autogene cevumeran, in patients with pancreatic ductal carcinoma demonstrates that the vaccine can induce T cell activity that may correlate with delayed recurrence of disease.
Source: NatureCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Thread by @TheVinodLab on Thread Reader App - 12 month(s) ago
@TheVinodLab: 1. ENTER #mRNAvaccines for #pancreaticcancer! Long-term #PDAC survivor story PART3. “Do #PDACs REALLY have vaccine neoantigens (NAs)”? (aren’t they lowly mutated?) If each patient = own NAs, how do you……
Source: threadreaderapp.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 2Una vacuna de ARN logra un primer éxito contra el cáncer de páncreas, el tumor más letal - 12 month(s) ago
Ocho pacientes responden de forma positiva a un tratamiento experimental combinado con fármacos convencionales
Source: EL PAÍSCategories: Hem/Oncs, Latest HeadlinesTweet
Randomized phase 2 trial of #mRNAvaccines for #pancreaticcancer NOW OPEN @MSKCancerCenter! More info on enrollment👇🏽 https://t.co/TXKZZTPD2R What did we find in the phase 1?👇🏽 https://t.co/8ndGZADgDH